About Contact Us Careers

Acromegaly Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2696
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Acromegaly Treatment Landscape

Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Chiasma Inc.
Novartis AG
Ipsen Biopharmaceuticals Inc
Wockhardt.
Troikaa Pharmaceuticals Ltd.
VHB Life Sciences Limited
GlaxoSmithKline plc.
Amryt Pharma plc
Antisense Therapeutics Limited

Browse Key Market Insights with Data Illustration:

Acromegaly Treatment Market Size & Share - Growth Report 2037

In the News

March 2020: Chiasma, a clinical-stage biopharmaceutical company, is developing an oral form of the drug octreotide for the maintenance treatment of acromegaly in adults which are not yet approved by the U.S. FDA. According to their research, octreotide capsules have the potential to work as an alternative to current injection therapy.

Author Credits: Radhika Pawar

Report ID: 2696
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of acromegaly treatment is estimated at USD 2.39 billion.

Acromegaly Treatment Market size was valued at USD 2.28 billion in 2024 and is likely to cross USD 4.57 billion by 2037, expanding at more than 5.5% CAGR during the forecast period i.e., between 2025-2037.

North America industry is estimated to dominate majority revenue share by 2037, attributed to factors such as availability of reimbursement, favorable government policies, an increase in the occurrence of pituitary tumors leading to acromegaly and gigantism, technological advancements, and rising awareness among people around the diagnosis of the disease in the region.

The major players in the market are Chiasma Inc., Novartis AG, Ipsen Biopharmaceuticals Inc, Wockhardt., Troikaa Pharmaceuticals Ltd., VHB Life Sciences Limited, GlaxoSmithKline plc., Amryt Pharma plc, Antisense Therapeutics Limited, and others.

Inquiry Before Buying Request Free Sample